Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells

Life Sciences

Volumn 64, Issue 21, 1999, Pages 1869-1876

  Shen, Fei ^a   Herenyiova, Maria ^a   Weber, George ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IP3 concentration; Ovarian carcinoma; Quercetin; Signal transduction; Tiazofurin

Indexed keywords

FLAVONOID; GUANOSINE TRIPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE; NUCLEOSIDE DERIVATIVE; PHOSPHATIDYLINOSITOL KINASE; QUERCETIN; TIAZOFURIN;

ARTICLE; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; OVARY CARCINOMA; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL CYCLE; DOWN-REGULATION; DRUG SYNERGISM; FEMALE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; OVARIAN NEOPLASMS; QUERCETIN; RIBAVIRIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033574586     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00133-2     Document Type: Article

References (22)

1. G. Weber, F. Shen, N. Prajda, H. Yang, W. Li, Y.A. Yeh, B. Csokay, E. Olah and K.Y. Look, Advan. Enzyme Regul. 37 35-55 (1997).
2. G. Weber, Cancer Res. 43 3466-3492 (1983).
3. E. Olah, B. Csokay, N. Prajda, Z. Kote-Jarai, Y.A. Yeh and G. Weber, Anticancer Res. 16 1-9 (1996).
4. D.A. Cooney, H.N. Jayaram, R.I. Glazer, J.A. Kelley, V.E. Marquez, G. Gebeyehu, A.C. Van Cott, L.A. Zwelling and D.G. Johns, Advan. Enzyme Regul. 21 271-303 (1983).
5. G. Weber, M. Nagai, Y. Natsumeda, J.N. Eble, H.N. Jayaram, E. Paulik, W. Zhen, R. Hoffman and G. Tricot, Cancer Commun. 3 61-66 (1991).
6. G. Tricot and G. Weber, Anticancer Res. 16 3341-3348 (1996).
7. H.N. Jayaram, R.L. Dion, R.I. Glazer, D.G. Johns, R.K. Robins, P.C. Srivastava and D.A. Cooney, Biochem. Pharmacol. 37 2371-2380 (1982).
8. B. Liu, D. Anderson, D.R. Ferry, L.W. Seymour, P.G. Takats and D.J. Kerr, J. Chromatogr. B Biomed. Appl. 666 149-155 (1995).
9. G. Weber, F. Shen, N. Prajda, Y.A. Yeh, H. Yang, M. Herenyiova and K.Y. Look, Anticancer Res. 16 3271-3282 (1996).
10. Y.Q. Wei, X. Zhao, Y. Kariya, H. Fukata, K. Teshigawara and A. Uchida, Cancer Res. 54 4952-4957 (1994).
11. H. Nishioka, M. Imoto, T. Sawa, M. Hamada, H. Naganawa, T. Takeushi and K. Umezawa, J. Antibiotics 42 823-825 (1989).
12. M. Yoshida, T. Sakai, N. Hosokawa, N. Marui, K. Matsumoto, A. Fujioka, H. Nishino and A. Aoike, FEBS Lett. 260 10-13 (1990).
13. N. Hosokawa, Y. Hosokawa, T. Sakai, M. Yoshida, N. Marui, H. Nishino, K. Kawai and A. Aoike, Int. J. Cancer 45 1119-1124 (1990).
14. F. Shen and G. Weber, Oncology Res. 9 597-602 (1997).
15. F. Shen and G. Weber, Oncology Res. 10 325-331 (1998).
16. T.C. Chou and P. Talalay, Advan. Enzyme Regul. 22 27-55 (1984).
17. J.L. Webb, Enzyme and Metabolic Inhibitors, Vol. 1. New York: Academic Press, pp. 507-510 (1963).
18. M.C. Berenbaum, Advan. Cancer Res. 35 269-335 (1981).
19. M.J. Berridge, Nature 361 315-325 (1993).
20. E. Olah, Y. Natsumeda, T. Ikegami, Z. Kote, M. Horanyi, J. Szelenyi, E. Paulik, T. Kremmer, S.R. Hollan, J. Sugar and G. Weber, Proc. Natl. Acad. Sci. U.S.A. 85 6533-6537 (1988).
21. T. Taniki, N. Prajda, Y. Monden and G. Weber, Cancer Biochem. Biophys. 13 295-302 (1993).
22. Y.A. Yeh, E. Olah, J.J. Wendel, G.W. Sledge, Jr. and G. Weber, Life Sci 54 431-435 (1994).